These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

760 related articles for article (PubMed ID: 23423669)

  • 1. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
    Reetz K; Costa AS; Mirzazade S; Lehmann A; Juzek A; Rakowicz M; Boguslawska R; Schöls L; Linnemann C; Mariotti C; Grisoli M; Dürr A; van de Warrenburg BP; Timmann D; Pandolfo M; Bauer P; Jacobi H; Hauser TK; Klockgether T; Schulz JB;
    Brain; 2013 Mar; 136(Pt 3):905-17. PubMed ID: 23423669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
    Schulz JB; Borkert J; Wolf S; Schmitz-Hübsch T; Rakowicz M; Mariotti C; Schöls L; Timmann D; van de Warrenburg B; Dürr A; Pandolfo M; Kang JS; Mandly AG; Nägele T; Grisoli M; Boguslawska R; Bauer P; Klockgether T; Hauser TK
    Neuroimage; 2010 Jan; 49(1):158-68. PubMed ID: 19631275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias.
    Della Nave R; Foresti S; Tessa C; Moretti M; Ginestroni A; Gavazzi C; Guerrini L; Salvi F; Piacentini S; Mascalchi M
    Neuroimage; 2004 Jun; 22(2):698-705. PubMed ID: 15193598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study.
    Guerrini L; Lolli F; Ginestroni A; Belli G; Della Nave R; Tessa C; Foresti S; Cosottini M; Piacentini S; Salvi F; Plasmati R; De Grandis D; Siciliano G; Filla A; Mascalchi M
    Brain; 2004 Aug; 127(Pt 8):1785-95. PubMed ID: 15240431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of grey and white matter reduction in spinocerebellar ataxia type 3 and 6: a voxel-based morphometry study.
    Lukas C; Schöls L; Bellenberg B; Rüb U; Przuntek H; Schmid G; Köster O; Suchan B
    Neurosci Lett; 2006 Nov; 408(3):230-5. PubMed ID: 17005321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gray matter volume deficits in spinocerebellar ataxia: an optimized voxel based morphometric study.
    Goel G; Pal PK; Ravishankar S; Venkatasubramanian G; Jayakumar PN; Krishna N; Purushottam M; Saini J; Faruq M; Mukherji M; Jain S
    Parkinsonism Relat Disord; 2011 Aug; 17(7):521-7. PubMed ID: 21600833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
    Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
    Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of fractional anisotropy changes in white matter of cerebellar peduncles distinguish spinocerebellar ataxia-1 from multiple system atrophy and other ataxia syndromes.
    Prakash N; Hageman N; Hua X; Toga AW; Perlman SL; Salamon N
    Neuroimage; 2009 Aug; 47 Suppl 2():T72-81. PubMed ID: 19446636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17).
    Lasek K; Lencer R; Gaser C; Hagenah J; Walter U; Wolters A; Kock N; Steinlechner S; Nagel M; Zühlke C; Nitschke MF; Brockmann K; Klein C; Rolfs A; Binkofski F
    Brain; 2006 Sep; 129(Pt 9):2341-52. PubMed ID: 16760196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gray and white matter alterations in spinocerebellar ataxia type 7: an in vivo DTI and VBM study.
    Alcauter S; Barrios FA; Díaz R; Fernández-Ruiz J
    Neuroimage; 2011 Mar; 55(1):1-7. PubMed ID: 21147232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics.
    Della Nave R; Ginestroni A; Tessa C; Salvatore E; De Grandis D; Plasmati R; Salvi F; De Michele G; Dotti MT; Piacentini S; Mascalchi M
    Neuroimage; 2008 Oct; 43(1):10-9. PubMed ID: 18672073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebellar Volumetry in Ataxias: Relation to Ataxia Severity and Duration.
    Ferreira M; Schaprian T; Kügler D; Reuter M; Deike-Hoffmann K; Timmann D; Ernst TM; Giunti P; Garcia-Moreno H; van de Warrenburg B; van Gaalen J; de Vries J; Jacobi H; Steiner KM; Öz G; Joers JM; Onyike C; Povazan M; Reetz K; Romanzetti S; Klockgether T; Faber J
    Cerebellum; 2024 Aug; 23(4):1521-1529. PubMed ID: 38363498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional MRI abnormalities of cerebellar cortex and nuclei in SCA3, SCA6 and Friedreich's ataxia.
    Stefanescu MR; Dohnalek M; Maderwald S; Thürling M; Minnerop M; Beck A; Schlamann M; Diedrichsen J; Ladd ME; Timmann D
    Brain; 2015 May; 138(Pt 5):1182-97. PubMed ID: 25818870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestation, imaging, and genotype analysis of two pedigrees with spinocerebellar ataxia.
    Peipei L; Yang L; Weihong G; Xiaonan S
    Cell Biochem Biophys; 2011 Dec; 61(3):691-8. PubMed ID: 21739264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spinocerebellar ataxias type 1 and 2: comparison of clinical, electrophysiological and magnetic resonance evaluation].
    Rakowicz M; Zdzienicka E; Poniatowska R; Waliniowska E; Sułek A; Jakubowska T; Niedzielska K; Rola R; Wierzbicka A; Hoffman-Zacharska D; Głazowski C; Jakubczyk T; Niewiadomska M; Zaremba J
    Neurol Neurochir Pol; 2005; 39(4):263-275. PubMed ID: 16096942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinocerebellar ataxia type 1 (SCA1): new pathoanatomical and clinico-pathological insights.
    Rüb U; Bürk K; Timmann D; den Dunnen W; Seidel K; Farrag K; Brunt E; Heinsen H; Egensperger R; Bornemann A; Schwarzacher S; Korf HW; Schöls L; Bohl J; Deller T
    Neuropathol Appl Neurobiol; 2012 Dec; 38(7):665-80. PubMed ID: 22309224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain structural damage in spinocerebellar ataxia type 2. A voxel-based morphometry study.
    Della Nave R; Ginestroni A; Tessa C; Cosottini M; Giannelli M; Salvatore E; Sartucci F; De Michele G; Dotti MT; Piacentini S; Mascalchi M
    Mov Disord; 2008 Apr; 23(6):899-903. PubMed ID: 18311829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pontine atrophy precedes cerebellar degeneration in spinocerebellar ataxia 7: MRI-based volumetric analysis.
    Bang OY; Lee PH; Kim SY; Kim HJ; Huh K
    J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1452-6. PubMed ID: 15377695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
    Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
    Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.